GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.
about
Enhanced glycogen synthase kinase-3β activity mediates podocyte apoptosis under diabetic conditions.Fine-tuning of NFκB by glycogen synthase kinase 3β directs the fate of glomerular podocytes upon injury.Visualizing the mouse podocyte with multiphoton microscopy.Drug discovery in focal and segmental glomerulosclerosismTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.The Vac14-interaction network is linked to regulators of the endolysosomal and autophagic pathway.Chromosome territory relocation during DNA repair requires nuclear myosin 1 recruitment to chromatin mediated by ϒ-H2AX signaling.Diet-induced obesity and kidney disease - In search of a susceptible mouse model.Regulation of mineral metabolism by lithium.Whether lithium inhibits glycogen synthase kinase (GSK)-3β activity in vivo in humans is still an open question.GSK3β regulates milk synthesis in and proliferation of dairy cow mammary epithelial cells via the mTOR/S6K1 signaling pathway.
P2860
Q35303442-5058E788-0F7E-44F9-94F8-3CA9840E8D9CQ35667727-5E409A55-A971-4231-ACFF-39AC5FFBFB6FQ36456525-93D38D18-7B9E-4AA8-89A0-0D195F150499Q36924116-B02F9D40-0D45-486B-9220-BD916C03F7E6Q38962103-A3C0B369-18FF-48CC-9201-983F371DD11EQ40372975-529A1AD9-95ED-48F8-B6C0-FF7D4440E388Q41220276-9B25F732-661B-4DD5-9A07-1B2DB1791093Q42062261-274558A0-EF48-4E03-8DE7-99CCF2E639C3Q46734017-F8162240-EB2E-4262-9FBE-07C2C3883D08Q54183701-AFB4081A-DF63-427D-B94B-8E7B2317C7BAQ54339980-138D3803-0648-4866-98F2-04F7E074049E
P2860
GSK3β inactivation in podocytes results in decreased phosphorylation of p70S6K accompanied by cytoskeletal rearrangements and inhibited motility.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@en
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@nl
type
label
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@en
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@nl
prefLabel
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@en
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@nl
P2093
P2860
P1476
GSK3β inactivation in podocyte ...... ements and inhibited motility.
@en
P2093
Beate Vollenbröker
Britta George
Hermann Pavenstädt
Moin A Saleem
Thomas Weide
Tobias B Huber
P2860
P304
P356
10.1152/AJPRENAL.00373.2010
P577
2011-01-12T00:00:00Z